SARS-CoV-2 Coronavirus

The BD Veritor™ At-Home COVID-19 Test is testing for the presence or absence of nucleocapsid antigens from SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), which causes the disease Coronavirus Disease 2019 (COVID-19). The test also contains an internal control mechanism to confirm, without the presence of a healthcare provider, that a human sample is collected.

This is not an antibody test.

This test is authorized for anyone aged 2+ (ages 2-13 require adult-assisted collection whereas ages 14+ can self-collect; ages 14-18 will require a parent or guardian to consent to testing in the Scanwell® Health app)

Not intended for individuals experiencing severe COVID-19 symptoms who should seek emergency medical care right away.

• General Symptoms

• • Fever between 100.4°F - 102°F
• • Flu-like symptoms (chills, runny or stuffy nose, whole body aches, a headache, and/or feeling tired)
• • New loss of taste or smell

• Respiratory Symptoms

• • A new or worsening cough or sore throat
• • Coughing
• • Shortness of breath

Everything you need to collect and test your sample and understand your results at home

FDA EUA authorized & reliable

The BD Veritor™ At-Home COVID-19 Test meets all accuracy requirements as defined by the FDA. The performance was measured during a clinical study that compared the BD Veritor™ At-Home COVID-19 Test results to an FDA Emergency Use Authorized high sensitivity PCR (molecular) test. Positive Percent Agreement (PPA) and Negative Percent Agreement (NPA) for symptomatic individuals were 84.6% and 99.8%, respectively. The performance of this test has not yet been clinically validated for use in patients without signs and symptoms of respiratory infection.

This product has not been FDA cleared or approved but has been authorized by FDA under an Emergency Use Authorization (EUA). This product has been authorized only for the detection of proteins from SARS- CoV-2, not for any other viruses or pathogens. This product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. §360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

Affordable

For purchases made after January 15th, 2022, the BD Veritor™ At-Home COVID-19 Test cost is eligible for reimbursement up to $12 per individual test with private health insurance. Once your order is complete, you can contact your health insurance provider for reimbursement. Always check with your insurance provider to verify benefits coverage before purchase. Everlywell is not enrolled in the Medicare program, and this test is ineligible for Medicare reimbursement, but may be eligible for Medicare Advantage reimbursement.

Promotions and discounts do not apply.
Please refer to our refund policy here.